Respa-Br Oral Tablet, Extended Release 11Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • Weekly Ad

Respa-BR: Oral tablet, extended release (11mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

BROMPHENIRAMINE (brome fen IR a meen) is an antihistamine. It is used to treat the symptoms of seasonal and year-round allergies. It is also used to treat a runny nose from a cold.

In-Depth Information

Respa-BR 11mg Extended-Release Tablet

NDC: 605750786
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)




Labeled but not FDA approved for the following conditions:
Pruritus, Angioedema, Vasomotor Rhinitis, Dermatographism, Anaphylaxis, Allergic Conjunctivitis, Urticaria, Allergic Rhinitis, Sneezing, Rhinorrhea, Common Cold

Respa-BR 11mg Extended-Release Tablet
Daily Life Interactions for Respa-BR 11mg Extended-Release Tablet

Elements of your daily lifestyle may have an effect on the medications you are taking. Drug interactions can result in unwanted side effects, reduce the effectiveness of your medicine or possibly increase the action of a particular medicine.

Major Lifestyle Interaction
Alcohol and Respa-BR 11mg Extended-Release Tablet(Brompheniramine Maleate)
Alcohol and CNS Depressants(Brompheniramine Maleate)
Avoid alcohol-containing drinks while taking this medicine. Using this drug along with alcohol can lead to serious side effects. You may feel drowsy or more tired when taking these drugs together. Do not drive or operate machinery until you know how this drug affects you, and especially if you are drinking alcohol-containing beverages. If you notice slurred speech, confusion, severe weakness, or difficulty breathing, contact your health care provider immediately.
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Avoid - This drug is known to cause harm to infants when taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Respa-BR

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5